API development and manufacturing for the pharmaceutical industry – Hovione

Hovione is a global company with over 50 years’ experience in API and Drug Product Intermediate development and compliant manufacture. With four FDA inspected sites in U.S., Ireland, Portugal and China, Hovione employs 1,200 people worldwide and has more than 1300m3 of flexible production capacity. Utilising innovative technologies and methodologies, and with a global footprint, Hovione is an integrated solution provider to the pharmaceutical industry. Hovione offers technologies as well as integrated API solutions for all drug delivery systems, from oral to injectable and from inhalation to topical applications. Specialising in complex chemistry and particle engineering, Hovione undertakes all services related to the development and manufacture as well as formulation development and clinical supply of the final dosage form to Phase II. The company offers a series of innovative particle engineering technologies to solve problems such as poor bioavailability, patient acceptability or enabling optimal delivery by non-oral routes of administration. These fall into three categories: • Crystal design (e.g. controlled crystallisation, co-crystals) • Particle size reduction (e.g. jet milling, wet polishing, and nanoparticle generation) • Amorphous solid dispersions (e.g. spray drying, hot melt extrusion, spray congealing, inclusion complexes). Our aim is to do well what is difficult and to give our customers what they cannot find elsewhere. www.hovione.com

---

---